Trial
NCT00481832
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Lymphoma, Non-Hodgkin
Intervention
Cyclophosphamide
Why stopped
Accrual Factor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-14